Veterinary Drugs Market Research Report by Key Players Analysis 2024

This report on the veterinary drugs market analyzes the current and future scenario of the global market. Increase in pet ownership, rise in healthcare expenditure on companion animals, rise in meat consumptions along with high demand for good quality proteins are some of the drivers expected to drive the global veterinary drugs market during the forecast period.

The global veterinary drugs market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on product type, animal type, route of administration and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global veterinary drugs market.

This 155 page report gives readers a comprehensive overview of the Veterinary Drugs Market. Browse through 24 data tables and 64 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/veterinary-drugs-market.html

Based on product type, the market has been segmented into anti-infective, anti-inflammatory, parasiticides, and others. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from veterinarians for treating the animals with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on animals, the global veterinary drugs market has been segmented into companion animals and livestock animals. The market segments have been extensively analyzed based on increase in demand for disease treatment among companion animals and livestock animals. Increase in pet ownership, demand for infection free meat, and increase in awareness for treatment of the domesticated animals are driving the market share of animal segment. Different types of route of administration are used to feed the drug to animals. On basis of route of administration global veterinary drugs market is segmented into oral, parenteral, and topical route of administration. Under the route of administration segment, oral administration of drugs in animals plays a major role followed by parenteral. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Get accurate market forecast and analysis on the Veterinary Drugs Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21152

Geographically, the global veterinary drugs market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

The report also profiles major players in the global veterinary drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global veterinary drugs market are Bayer AG., Boehringer Ingelheim GmbH, Ceva Santé Animale, Dechra Pharmaceuticals PLC., Elanco Animal Health (Eli Lilly and Company), Merck & Co., Inc., Virbac, Vetoquinol, Zoetis, Inc. and others.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.